Recombinant CCR2 (Plozalizumab Biosimilar) antibody

Catalog No. ABIN7666113

The Human Monoclonal anti-CCR2 (Plozalizumab Biosimilar) antibody has been validated for . It is suitable to detect CCR2 (Plozalizumab Biosimilar) in samples from Human.

Quick Overview for Recombinant CCR2 (Plozalizumab Biosimilar) antibody (ABIN7666113)

Target: CCR2 (Plozalizumab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Human

Clonality: Monoclonal

Conjugate: This CCR2 (Plozalizumab Biosimilar) antibody is un-conjugated

Application: Please inquire

Product Details anti-CCR2 (Plozalizumab Biosimilar) Antibody

Expression System: CHO Cells

Purpose: CCR2 antibody (Plozalizumab biosimilar)

Purity: ≥95 % (SDS-PAGE&SEC)

Isotype: IgG1

Application Details

Restrictions: For Research Use only

Handling

Format: Liquid

Storage Comment: Please store the product under the recommended conditions in the the instructions.

Target Details for CCR2 (Plozalizumab Biosimilar)

Target: CCR2 (Plozalizumab Biosimilar)

Alternative Name: Plozalizumab biosimilar

Target Type: Biosimilar

Background: Plozalizumab | CCR2

Gene ID: 729230

UniProt: P41597